Although the reduction in phosphorylated p38 MAPK was 19%, this decrease did not reach statistical significance (Figure 7F, G ).
← all excerpts
Ramalin Ameliorates Alzheimer's Disease Pathology by Targeting BACE1, HDAC6, and MAPK Pathways.
1
—
—
Although the reduction in phosphorylated p38 MAPK was 19%, this decrease did not reach statistical significance (Figure 7F, G ).